Citius Oncology holds annual shareholder meeting

PUBT · 1d ago
Citius Oncology holds annual shareholder meeting
  • Citius Oncology held its annual stockholders meeting on September 29, 2026.
  • Stockholders backed the election of three Class II directors: Eugene Holuka, Robert Smith, Carol Webb.
  • Shareholders ratified Wolf & Company, P.C. as independent registered public accounting firm for the fiscal year ended September 30, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-104694), on September 29, 2026, and is solely responsible for the information contained therein.